Microdosing, neuropsychedelia and psilocybin remedy are just some of the matters that can be mentioned at a free day-long seminar and webinar at UC Davis Well being in Sacramento on March 23.
The Psychedelic Summit will convey collectively nationwide specialists to discover what the quickly evolving discipline of psychedelics and neurotherapeutics might imply for neuropsychiatric and neurodegenerative ailments. These new remedy varieties might maintain promise for nervousness, melancholy, substance use, obsessive-compulsive and post-traumatic stress issues, amongst others.
David Lubarsky, vice chancellor of Human Well being Sciences and CEO of UC Davis Well being, will introduce the occasion. The Psychedelic Summit is hosted by the UC Davis Division for Psychiatry and Behavioral Sciences, the Institute for Psychedelics and Neurotherapeutics and the Behavioral Well being Heart of Excellence.
Audio system
David E. Olson, College of California, Davis
Psychedelics and Plasticity-Selling Neurotherapeutics
Mark Geyer, College of California, San Diego
Neuropsychedelia: From Psychotomimetics to Psychotherapeutics
Joshua Wooley, College of California, San Francisco
Researching Psilocybin Remedy: Present Challenges and Future Prospects
Harriet De Wit, College of Chicago
Microdosing: Reality or Fiction?
Frederick Streeter Barrett, Johns Hopkins College
Neural and Psychological Mechanisms of Motion of Basic Psychedelic Medication
Dhakshin Ramanathan, College of California, San Diego
Past Psychedelics: Augmenting Temper Enhancing Results with Customized Plasticity-Primarily based Interventions
Conor Liston, Weill Cornell Drugs
Probing and Rescuing Dysfunctional Mind Circuits in Despair
Register
The Psychedelic Summit can be held on the MIND Institute Auditorium on March 23 from 9 a.m. to five p.m. Pacific Daylight Time. Restricted seating is on the market in individual. For in-person attendance, register right here. For digital attendance, register right here.
